Status:
RECRUITING
Platelet Function and Impella Support
Lead Sponsor:
Università Vita-Salute San Raffaele
Collaborating Sponsors:
Abiomed Inc.
Conditions:
Cardiogenic Shock
Cardiac Arrest
Eligibility:
All Genders
18-75 years
Brief Summary
Mechanical circulatory support (MCS) with the Impella microaxial pump in the setting of cardiogenic shock/cardiac arrest (CS/CA) is accompanied by substantial risk of life-threatening complications, i...
Detailed Description
STUDY DESIGN AND MAIN OBJECTIVE Prospective observational study to evaluate changes in the expression levels of markers of platelet function (activation and aggregation capacity) in CS/CA patients who...
Eligibility Criteria
Inclusion
- Patients \>18yrs-old and \<75yrs-old
- Cardiogenic shock SCAI class C-D-E
- primary tMCS with an Impella device (all Impella pumps)
- Informed consent
Exclusion
- Patients \<18yrs-old or \>75yrs-old
- Refusal to participate to the study
Key Trial Info
Start Date :
February 24 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06487091
Start Date
February 24 2025
End Date
January 31 2027
Last Update
April 13 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele Hospital
Milan, Italy, 20132
2
Università Vita Salute San Raffaele
Milan, Italy, 20132